Unity Biotechnology, Inc. Revenue
Unity Biotechnology, Inc. reported Revenue of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-03-07
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $0.00.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-06-30 was $236.00K.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $0.00.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $236.00K, a 95.07% decline from fiscal 2021.
- Unity Biotechnology, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $4.78M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-07 | |||
| 2023-06-30 | $0.00 10-K · filed 2024-04-15 | $0.00 10-K · filed 2024-04-15 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2025-03-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $236.00K derived: sum of 3 quarters · filed 2025-03-07 | $236.00K 10-K · filed 2025-03-07 |
| 2022-09-30 | $0.00 10-K · filed 2024-04-15 | $236.00K derived: sum of 2 quarters · filed 2024-04-15 | $236.00K 10-K · filed 2024-04-15 | |
| 2022-06-30 | $236.00K 10-Q · filed 2023-08-08 | $236.00K 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | $4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $4.78M derived: sum of 2 quarters · filed 2024-04-15 | $4.78M derived: sum of 3 quarters · filed 2024-04-15 | $4.78M 10-K · filed 2024-04-15 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 |